UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Failure of the Adipocytokine, Resistin, to Protect the Heart From Ischemia-Reperfusion Injury

Smith, CCT; Lim, SY; Wynne, AM; Sivaraman, V; Davidson, SM; Mocanu, MM; ... Yellon, DM; + view all (2011) Failure of the Adipocytokine, Resistin, to Protect the Heart From Ischemia-Reperfusion Injury. J CARDIOVASC PHARM T , 16 (1) 63 - 71. 10.1177/1074248410382232.

Full text not available from this repository.

Abstract

Experimental studies have linked the adipocytokines with acute cardioprotection. Whether the adipocytokine, resistin, confers protection is, however, debatable. In the current study, the actions of resistin, administered at reperfusion, were investigated in in vivo and in vitro rodent and in vitro human models of myocardial ischemia-reperfusion (I/R) injury. Resistin did not reduce infarct size in Langendorff-perfused rat hearts or murine hearts perfused in vivo. Resistin also did not protect human atrial muscle subjected to hypoxia-reoxygenation. Although cyclosporin A delayed mitochondrial permeability transition pore (MPTP) opening in murine cardiomyocytes, resistin was ineffective. Western blot analysis revealed that resistin treatment was associated with enhanced phosphorylation of Akt, at both the serine-473 (+51.9%, P = .01) and threonine-308 (+107%, P < .01) phosphorylation sites, although not to the extent seen with ischemic preconditioning (+132.5%, P - .002 and +389.1%, P < .01, respectively). We conclude that resistin administered at reperfusion at concentrations/doses equivalent to normal (upper end) and pathological serum levels does not protect against I/R injury or inhibit MPTP opening.

Type:Article
Title:Failure of the Adipocytokine, Resistin, to Protect the Heart From Ischemia-Reperfusion Injury
DOI:10.1177/1074248410382232
Keywords:resistin, cardioprotection, ischemia-reperfusion injury, RISK pathway, PERMEABILITY TRANSITION PORE, HUMAN ENDOTHELIAL-CELLS, HUMAN ATRIAL MUSCLE, INSULIN-RESISTANCE, UP-REGULATION, IN-VITRO, OBESITY, ADIPONECTIN, ACTIVATION, HORMONE
UCL classification:UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Medicine (Division of) > Cardiovascular Medicine
UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science

Archive Staff Only: edit this record